Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron Jul 28, 2021 4:30pm

97 Views

Post# 33618062

todays trades

House Positions for C:VXL from 20210728 to 20210728

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
2 RBC	85,000	7,480	0.088	11,000	990	0.09	74,000	-6,490
9 BMO Nesbitt	20,000	1,700	0.085	0			20,000	-1,700
33 Canaccord	13,000	1,040	0.08	0			13,000	-1,040
212 Virtu	1,384	117	0.085	11	0	0.00	1,373	-117
57 Interactive	0			1,000	85	0.085	-1,000	85
68 Leede	1,548	131	0.085	2,593	220	0.085	-1,045	89
14 ITG	11	0	0.00	1,384	117	0.085	-1,373	117
79 CIBC	0			2,000	172	0.086	-2,000	172
19 Desjardins	0			6,000	540	0.09	-6,000	540
80 National Bank	4,250	371	0.087	16,001	1,308	0.082	-11,751	937
1 Anonymous	1,000	85	0.085	15,500	1,322	0.085	-14,500	1,237
7 TD Sec	36,820	3,129	0.085	54,548	4,796	0.088	-17,728	1,667
85 Scotia	13,024	1,141	0.088	66,000	5,645	0.086	-52,976	4,504
TOTAL	176,037	15,194	0.086	176,037	15,195	0.086	0	1